EPIC |
HLN |
Sector |
Pharma and Biotech |
ISIN |
GB00BMX86B70 |
Market Sector |
MAIN |
Market Segment |
SET1 |
Main Indices |
FTSE 100, FTSE 350, FTSE All-Share |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£30,128m |
NMS |
7,500 |
Shares in issue |
9,132m |
Date Listed |
n/a |
|
Final |
Interim |
Ex-Div |
14-Mar-24 |
24-Aug-23 |
Paid |
16-May-24 |
05-Oct-23 |
Amount |
4.20p |
1.80p |
16:35 |
1,359,008 @ 329.46p |
16:35 |
766,824 @ 329.46p |
16:35 |
5,998,715 @ 329.90p |
16:35 |
947 @ 329.90p |
16:35 |
4,260 @ 329.90p |
CFO |
Tobias Hestler |
CEO |
Brian McNamara |
CEO |
Deirdre Mahlan |
Top of Page
You are here:
research